ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1523

Ischemia Modified Albumin Levels in Rheumatoid Arthritis

Ali Ugur Uslu1, Adem Kucuk2, Sevket Balta3, Sevket Arslan4, Levent Tekin5, Sami Kucuksen6, Aysun Toker7 and Mehmet Kayrak8, 1Internal Medicine, Eskisehir Military Hospital, Eskisehir, Turkey, 2Necmettin Erbakan U Meram T F, Necmettin Erbakan U Meram T F, Konya, Turkey, 3Cardiology, Eskisehir Military Hospital, Eskisehir, Turkey, 4Allergy and Clinical Immunology, Necmettin Erbakan University, Konya, Turkey, 5Physical Medicine and Rehabilitation, Beyhekim State Hospital, Konya, Turkey, 6MD, kONYA, Turkey, 7Biochemistry, Necmettin Erbakan University, Konya, Turkey, 8Necmettin Erbakan University, Division of Cardiology, Konya, Turkey

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Atherosclerosis, Cardiovascular disease, Inflammation, intima medial thickness and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  Cardiovascular
diseases, among which atherosclerotic heart disease, are known to be one of the
most important mortality and morbidity causes in patients with Rheumatoid
Arthritis (RA). Ischemia modified albumin (IMA) is a potential marker that can
be used to assess atherosclerosis-related myocardial ischemia. Another
frequently used marker for the assessment of atherosclerotic lesions is the
carotid intima media thickness (CIMT). To evaluate role that IMA has on
atherosclerosis development and its clinical usability in patients with RA, by
assessing the values of IMA and CIMT.

Methods: Our prospective study was conducted between June 2012 and March 2013 at
the rheumatology department of Meram Medical School. 52 RA patients, diagnosed
according to the criteria of the 1987 American College of Rheumatology, and an
age- and sex-matched control group of 46 healthy subjects were included in
this study.

Results: No significant difference was detected between the groups with respect
to age, sex and body mass index. Baseline laboratory characteristics of
patients and controls. In the patient’s group the IMA and CIMT values were
found to be 0.37±0.12 ABSU and 0.80±0.22 mm respectively while in the control
group were 0.31±0.11 ABSU and 0.51±0.18 mm respectively. The IMA and CIMT
values were significantly higher in the patient’s group (p=0.022 and
p<0.0001 respectively). A positive correlation was found between IMA, CIMT
and DAS-28 (p=0.016 and p=0.002 respectively) (Figure 1).

Conclusion: Since the values of IMA were higher in the patient’s
group compared to control and because of its correlation with CIMT, we suggest
the usage of IMA as an early marker of atherosclerosis in RA patients.

Figure
1. Correlation between IMA and CIMT


Disclosure: A. U. Uslu, None; A. Kucuk, None; S. Balta, None; S. Arslan, None; L. Tekin, None; S. Kucuksen, None; A. Toker, None; M. Kayrak, None.

To cite this abstract in AMA style:

Uslu AU, Kucuk A, Balta S, Arslan S, Tekin L, Kucuksen S, Toker A, Kayrak M. Ischemia Modified Albumin Levels in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/ischemia-modified-albumin-levels-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ischemia-modified-albumin-levels-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology